Glyphic Biotechnologies
The Assay Research Scientist will establish novel assay workflows and develop proxy assays to predict multi-cycle ProSE performance for Glyphic's protein sequencing platform. This role involves designing experiments to improve the efficiency and accuracy of the ProSE process while collaborating with cross-functional teams to define requirements for new components. The position requires a scientist with a strong background in molecular biology and chemistry to drive innovation in life science discovery.
Headquarters
Berkeley, California, United States
Company Size
11-50 employees
Founded
2021
Glyphic Biotechnologies is a Berkeley, CA-based biotechnology company founded in 2021, developing next-generation protein sequencing technology. Their proprietary Protein Sequencing by Expansion (ProSE™) platform enables de novo, high-throughput proteome sequencing with single-molecule sensitivity, capable of discriminating all 20 amino acids and post-translational modifications (PTMs). Glyphic aims to advance life science discovery by delivering unprecedented precision, scalability, and accessibility in proteomics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Glyphic Biotechnologies.